Annual EBITDA:
-$101.45M-$53.63M(-112.16%)Summary
- As of today, DNTH annual EBITDA is -$101.45 million, with the most recent change of -$53.63 million (-112.16%) on December 31, 2024.
- During the last 3 years, DNTH annual EBITDA has fallen by -$28.78 million (-39.60%).
- DNTH annual EBITDA is now -995.36% below its all-time high of -$9.26 million, reached on December 1, 2016.
Performance
DNTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$34.83M-$1.78M(-5.40%)Summary
- As of today, DNTH quarterly EBITDA is -$34.83 million, with the most recent change of -$1.78 million (-5.40%) on June 30, 2025.
- Over the past year, DNTH quarterly EBITDA has dropped by -$12.73 million (-57.64%).
- DNTH quarterly EBITDA is now -628.92% below its all-time high of -$4.78 million, reached on March 1, 2017.
Performance
DNTH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$129.49M-$12.73M(-10.91%)Summary
- As of today, DNTH TTM EBITDA is -$129.49 million, with the most recent change of -$12.73 million (-10.91%) on June 30, 2025.
- Over the past year, DNTH TTM EBITDA has dropped by -$61.07 million (-89.26%).
- DNTH TTM EBITDA is now -2610.21% below its all-time high of -$4.78 million, reached on March 1, 2017.
Performance
DNTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNTH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -112.2% | -57.6% | -89.3% |
| 3Y3 Years | -39.6% | -106.2% | -68.5% |
| 5Y5 Years | -25.1% | -78.5% | -57.3% |
DNTH EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -243.2% | at low | -358.1% | at low | -219.7% | at low |
| 5Y | 5-Year | -243.2% | at low | -358.1% | at low | -219.7% | at low |
| All-Time | All-Time | -995.4% | at low | -628.9% | at low | -2610.2% | at low |
DNTH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$34.83M(-5.4%) | -$129.49M(-10.9%) |
| Mar 2025 | - | -$33.04M(-3.8%) | -$116.76M(-15.1%) |
| Dec 2024 | -$101.45M(-112.2%) | -$31.84M(-6.9%) | -$101.45M(-23.0%) |
| Sep 2024 | - | -$29.78M(-34.8%) | -$82.47M(-20.5%) |
| Jun 2024 | - | -$22.09M(-24.6%) | -$68.42M(-17.9%) |
| Mar 2024 | - | -$17.74M(-38.0%) | -$58.02M(-21.2%) |
| Dec 2023 | -$47.82M(-61.8%) | -$12.85M(+18.3%) | -$47.89M(-4.8%) |
| Sep 2023 | - | -$15.74M(-34.6%) | -$45.68M(-12.8%) |
| Jun 2023 | - | -$11.69M(-53.8%) | -$40.50M(+11.4%) |
| Mar 2023 | - | -$7.60M(+28.6%) | -$45.70M(+24.7%) |
| Dec 2022 | -$29.56M(+59.3%) | -$10.64M(-0.8%) | -$60.72M(+12.9%) |
| Sep 2022 | - | -$10.56M(+37.5%) | -$69.68M(+9.3%) |
| Jun 2022 | - | -$16.89M(+25.4%) | -$76.83M(+0.3%) |
| Mar 2022 | - | -$22.62M(-15.4%) | -$77.07M(-6.1%) |
| Dec 2021 | -$72.67M | - | - |
| Dec 2021 | - | -$19.61M(-10.7%) | -$72.67M(-1.4%) |
| Sep 2021 | - | -$17.71M(-3.4%) | -$71.64M(+0.2%) |
| Jun 2021 | - | -$17.13M(+6.0%) | -$71.81M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$18.22M(+1.9%) | -$74.20M(+3.3%) |
| Dec 2020 | -$76.72M(+5.4%) | -$18.57M(-3.8%) | -$76.72M(+6.8%) |
| Sep 2020 | - | -$17.89M(+8.4%) | -$82.31M(+4.9%) |
| Jun 2020 | - | -$19.52M(+5.9%) | -$86.58M(-0.7%) |
| Mar 2020 | - | -$20.75M(+14.1%) | -$85.95M(-5.9%) |
| Dec 2019 | -$81.13M(-37.3%) | -$24.15M(-9.0%) | -$81.13M(-8.8%) |
| Sep 2019 | - | -$22.16M(-17.3%) | -$74.55M(-8.2%) |
| Jun 2019 | - | -$18.89M(-18.6%) | -$68.88M(-7.9%) |
| Mar 2019 | - | -$15.93M(+9.4%) | -$63.86M(-8.1%) |
| Dec 2018 | -$59.09M(-67.1%) | -$17.57M(-6.5%) | -$59.09M(-42.3%) |
| Sep 2018 | - | -$16.49M(-19.0%) | -$41.52M(-30.1%) |
| Jun 2018 | - | -$13.87M(-24.2%) | -$31.92M(+5.3%) |
| Mar 2018 | - | -$11.16M(-61.8%) | -$33.69M(-23.4%) |
| Dec 2017 | -$35.35M(-281.7%) | - | - |
| Sep 2017 | - | -$6.90M(+55.9%) | -$27.31M(-33.8%) |
| Jun 2017 | - | -$15.63M(-227.2%) | -$20.41M(-327.2%) |
| Mar 2017 | - | -$4.78M | -$4.78M |
| Dec 2016 | -$9.26M | - | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Dianthus Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Dianthus Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of DNTH is -$101.45M
What is the all-time high annual EBITDA for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual EBITDA is -$9.26M
What is Dianthus Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, DNTH annual EBITDA has changed by -$53.63M (-112.16%)
What is Dianthus Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of DNTH is -$34.83M
What is the all-time high quarterly EBITDA for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly EBITDA is -$4.78M
What is Dianthus Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, DNTH quarterly EBITDA has changed by -$12.73M (-57.64%)
What is Dianthus Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of DNTH is -$129.49M
What is the all-time high TTM EBITDA for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high TTM EBITDA is -$4.78M
What is Dianthus Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, DNTH TTM EBITDA has changed by -$61.07M (-89.26%)